Screening Blood Donors for Human Immunodeficiency Virus Antibody: Cost-Benefit Analysis.

American Journal of Public Health - United States
doi 10.2105/ajph.78.4.450
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Public Health Association

Related search

Seroprevalence of Human Immunodeficiency Virus Infection Among Blood Donors of Central Karnataka

Tropical Journal of Pathology and Microbiology
2015English

Seroprevalance of Hepatitis B Virus, Human Immunodeficiency Virus and Hepatitis C Virus Among Blood Donors: A Retrospective Study

Tropical Journal of Pathology and Microbiology
2019English

Cost-Effectiveness Analysis of Partner Notification Program for Human Immunodeficiency Virus Infection in Japan

Journal of Epidemiology
MedicineEpidemiology
1998English

Persistent High Frequency of Human Immunodeficiency Virus-Specific Cytotoxic T Cells in Peripheral Blood of Infected Donors.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1995English

Maternal Serum Alpha-Fetoprotein Screening: A Cost-Benefit Analysis.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1979English

Assessment of Seroprevalance of Human Immunodeficiency Virus Infection Among Blood Donors in and Around Bellary, Karnataka State, India

Journal of Evolution of Medical and Dental Sciences
2014English

Evaluation of a New Combined Antigen and Antibody Human Immunodeficiency Virus Screening Assay, VIDAS HIV DUO Ultra

Journal of Clinical Microbiology
Microbiology
2002English

Structure-Function Analysis of the Epitope for 4E10, a Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2006English

Cost-Benefit Analysis

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy